Bli medlem
Bli medlem

Du är här

2016-04-11

Xvivo Perfusion: Annual Report 2015

Today XVIVO Perfusion is publishing the Annual Report for 2015 (in
Swedish). The Annual Report is attached to this press release and
will also be available on www.xvivoperfusion.com.

A printed version of the Annual Report 2015 can be ordered by phone
+46 (0)31 788 21 50 or by email info@xvivoperfusion.com.

April 11, 2016
Gothenburg
XVIVO Perfusion AB (publ)

For further information please contact:
Christoffer Rosenblad, CFO, +1 720 616 2101,
christoffer.rosenblad@xvivoperfusion.com

Magnus Nilsson, CEO, +46 31 788 2150,
magnus.nilsson@xvivoperfusion.com

For further information on XVIVO Perfusion's business, please refer to
the company's website, www.xvivoperfusion.com

The information was submitted for publication on April 11, 2016 at
8:30 a.m.

This is a translation of the Swedish version of the press release.
When in doubt, the Swedish wording prevails.

______________________________________________________________________________________________________________________

XVIVO Perfusion AB is a medical technology company which develops
solutions and systems for assessing and preserving organs outside the
body and for selecting usable organs and maintaining them in optimal
condition pending transplantation.

The company is headquartered in Gothenburg, Sweden, and has one office
in the USA. The XVIVO share is listed on NASDAQ First North premier
and has the ticker symbol XVIVO. More information can be found on the
website www.xvivoperfusion.com. The Certified Adviser is Redeye,
www.redeye.se.

______________________________________________________________________________________________________________________

XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate
identity number 556561-0424.

Tel: 46 31 788 21 50. Fax: 46 31 788 21 69.
E-mail: info@xvivoperfusion.com. Website: www.xvivoperfusion.com
-----------------------------------------------------------
http://news.cision.com/xvivo-perfusion/r/annual-report-2015,c9950842
http://mb.cision.com/Main/4567/9950842/497668.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.